The National Company Law Tribunal has officially admitted the second motion petition regarding the Scheme of Arrangement involving India Glycols Limited, Ennature Biopharma Limited, and IGL Spirits Limited. This development marks a significant step forward in the restructuring process. The next phase involves notifying relevant authorities and publishing public notices, with further proceedings scheduled for May 21, 2026, keeping the reorganization plan moving toward final approval.
Advancement of Restructuring Plan
Following previous shareholder and creditor meetings, the National Company Law Tribunal (NCLT) has formally admitted the second motion petition on April 9, 2026. This milestone is a critical step in the ongoing Scheme of Arrangement aimed at demerging specific business units. The process involves India Glycols Limited (the Demerged Company) along with Ennature Biopharma Limited and IGL Spirits Limited as the resulting entities.
Next Steps and Regulatory Compliance
As per the directive, the companies are now required to issue formal notices to various government and sectoral authorities. These authorities have a window of 30 days from the receipt of notice to submit any representations or feedback regarding the proposed scheme. Furthermore, the company will publish notices in two major national daily newspapers—Business Standard (English) and Amar Ujala (Hindi)—to ensure public transparency.
Looking Ahead
The entire arrangement remains subject to further regulatory reviews and final court approvals. The tribunal has set the date for further proceedings on May 21, 2026. Until then, all relevant documentation has been made available to stakeholders and the public via the company’s official communication channels, maintaining complete transparency as the restructuring process advances toward its conclusion.
Source: BSE
